Search Results - "Hong, Dongzhe"

Refine Results
  1. 1

    Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment by Monnette, Alisha, Chen, Er, Hong, Dongzhe, Bazzano, Alessandra, Dixon, Stacy, Arnold, W David, Shi, Lizheng

    Published in Orphanet journal of rare diseases (20-01-2021)
    “…To examine patient/caregiver preference for key attributes of treatments for spinal muscular atrophy (SMA). In the rapidly evolving SMA treatment landscape, it…”
    Get full text
    Journal Article
  2. 2

    The Impact of Reimbursement for Non–Face-to-Face Chronic Care Management on Comprehensive Metabolic Biomarkers Among Multimorbid Patients With Type 2 Diabetes by Shao, Yixue, Stoecker, Charles, Hong, Dongzhe, Nauman, Elizabeth, Fonseca, Vivian, Hu, Gang, Bazzano, Alessandra N., Fort, Daniel, Kabagambe, Edmond K., Shi, Lizheng

    Published in Medical care (01-03-2023)
    “…We evaluated the impact of reimbursement for non-face-to-face chronic care management (NFFCCM) on comprehensive metabolic risk factors among multimorbid…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Biosimilar Uptake In The US: Patient And Prescriber Factors by Hong, Dongzhe, Kesselheim, Aaron S, Sarpatwari, Ameet, Rome, Benjamin N

    Published in Health affairs (Millwood, Va.) (01-08-2024)
    “…Among 196,766 commercially insured and Medicare Advantage patients who newly initiated biologic drugs with available biosimilar versions, biosimilar initiation…”
    Get full text
    Journal Article
  7. 7

    Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review by Hong, Dongzhe, Si, Lei, Jiang, Minghuan, Shao, Hui, Ming, Wai-kit, Zhao, Yingnan, Li, Yan, Shi, Lizheng

    Published in PharmacoEconomics (01-06-2019)
    “…Objective This study aimed to systematically review cost-effectiveness studies of newer antidiabetic medications. Methods The PubMed/MEDLINE, EMBASE, CINAHL…”
    Get full text
    Journal Article
  8. 8

    Effects of Non-Face-to-Face Chronic Care Management on Service Utilization and Outcomes Among US Medicare Beneficiaries with Diabetes by Hong, Dongzhe, Stoecker, Charles, Shao, Yixue, Nauman, Elizabeth, Fonseca, Vivian, Hu, Gang, Bazzano, Alessandra N., Kabagambe, Edmond K., Shi, Lizheng

    “…Background Type 2 diabetes mellitus (T2DM) results in heavy economic and disease burdens in Louisiana. The Centers for Medicare and Medicaid Services has…”
    Get full text
    Journal Article
  9. 9

    Addressing Regional Differences in Diabetes Progression: Global Calibration for Diabetes Simulation Model by Shao, Hui, Yang, Shuang, Stoecker, Charles, Fonseca, Vivian, Hong, Dongzhe, Shi, Lizheng

    Published in Value in health (01-12-2019)
    “…To develop a practical solution for modeling diabetes progression and account for the variations in risks of diabetes complications in different regions of the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Health Utilization Among Patients With Type 2 Diabetes in Louisiana by Shao, Yixue, Stoecker, Charles, Hong, Dongzhe, Nauman, Elizabeth, Fonseca, Vivian, Hu, Gang, Bazzano, Alessandra N., Kabagambe, Edmond K., Shi, Lizheng

    Published in Value in health (01-05-2023)
    “…We evaluated the impact of reimbursement for non-face-to-face chronic care management (NFFCCM) on healthcare utilization among Medicare beneficiaries with type…”
    Get full text
    Journal Article
  13. 13

    Does the Encounter Type Matter When Defining Diabetes Complications in Electronic Health Records? by Hong, Dongzhe, Shen, Yun, Monnette, Alisha, Liu, Shuqian, Shao, Hui, Nauman, Elizabeth, Price-Haywood, Eboni, Hu, Gang, Shi, Lizheng

    Published in Medical care (01-06-2020)
    “…BACKGROUND:Electronic health records (EHRs) and claims records are widely used in defining type 2 diabetes mellitus (T2DM) complications across different types…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Characteristics of Patients Receiving Novel Muscular Dystrophy Drugs in Trials vs Routine Care by Hong, Dongzhe, Avorn, Jerry, Wyss, Richard, Kesselheim, Aaron S

    Published in JAMA network open (24-01-2024)
    “…The US Food and Drug Administration approved eteplirsen for Duchenne muscular dystrophy (DMD) in 2016 based on a controversial pivotal study that demonstrated…”
    Get full text
    Journal Article
  16. 16

    Cost Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors: A Systematic Review by Hong, Dongzhe, Si, Lei, Jiang, Minghuan, Shao, Hui, Ming, Wai-kit, Zhao, Yingnan, Li, Yan

    Published in PharmacoEconomics (01-06-2019)
    “…Objective This study aimed to systematically review cost-effectiveness studies of newer antidiabetic medications. Methods The PubMed/MEDLINE, EMBASE, CINAHL…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Electronic Medical Record Risk Modeling of Cardiovascular Outcomes Among Patients with Type 2 Diabetes by Hong, Dongzhe, Fort, Daniel, Shi, Lizheng, Price-Haywood, Eboni G.

    Published in Diabetes therapy (01-07-2021)
    “…Introduction Increased utilization of electronic health records (EHR) has enriched databases for creating risk models. We used machine learning techniques to…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Patient-specific factors associated with use of diabetes self-management education and support programs in Louisiana by Yoshida, Yilin, Hong, Dongzhe, Nauman, Elizabeth, Price-Haywood, Eboni G, Bazzano, Alessandra N, Stoecker, Charles, Hu, Gang, Shen, Yun, Katzmarzyk, Peter T, Fonseca, Vivian A, Shi, Lizheng

    Published in BMJ open diabetes research & care (01-12-2021)
    “…IntroductionThe prevalence of diabetes self-management education and support (DSME/S) use among patients with newly diagnosed type 2 diabetes mellitus (T2DM)…”
    Get full text
    Journal Article